Abstract:Compared to traditional branched polymers with Gd(III) chelates conjugated on their surface, branched polymers with Gd(III) chelates as the internal skeleton are considered to be a reasonable strategy for preparing efficient magnetic resonance imaging contrast agents. Herein, the Gd(III) ligand DOTA was chosen as the internal skeleton; four different molecular weights (3.5, 5.3, 8.6, and 13.1 kDa) and degrees of branching poly-DOTA branched polymers (P1, P2, P3, and P4) were synthesized by a simple "A2 + B4"-type one-pot polymerization. The Gd(III) chelates of these poly-DOTA branched polymers (P1-Gd, P2-Gd, P3-Gd, and P4-Gd) display excellent kinetic stability, which is significantly higher than those of linear Gd-DTPA and cyclic Gd-DOTA-butrol and slightly lower than that of cyclic Gd-DOTA. The T1 relaxivities of P1-Gd, P2-Gd, P3-Gd, and P4-Gd are 29.4, 38.7, 44.0, and 47.9 Gd mM-1 s-1, respectively, at 0.5 T, which are about 6-11 times higher than that of Gd-DOTA (4.4 Gd mM-1 s-1). P4-Gd was selected for in vivo magnetic resonance angiography (MRA) because of its high kinetic stability, T1 relaxivity, and good biosafety. The results showed excellent MRA effect, sensitive detection of vascular stenosis, and prolonged observation window as compared to Gd-DOTA. Overall, Gd(III) chelates of poly-DOTA branched polymers are good candidates of MRI probes, providing a unique design strategy in which Gd chelation can occur at both the interior and surface of the poly-DOTA branched polymers, resulting in excellent relaxivity enhancement. In vivo animal MRA studies of the probe provide possibilities in discovering small vascular pathologies.

Synthesis and evaluation of novel polysaccharide-Gd-DTPA compounds as contrast agent for MRI

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Synthesis and evaluation of Gd-DTPA-labeled arabinogalactans as potential MRI contrast agents

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents

Synthesis, Relaxivity And Biodistribution Of Novel Magnetic Resonance Imaging (Mri) Contrast Agents: Polylysine (Gd-Dtpa/Dota) With Pendent Galactose Moieties As Hepatocyte-Targeting Groups

Gadolinium(III) Complex-Backboned Branched Polymers As Imaging Probes for Contrast-Enhanced Magnetic Resonance Angiography

Comparison Between Gd-Dtpa and Several Bisamide Derivatives As Potential Mri Contrast Agents

Synthesis and Evaluation of Neutral Gd(III), Mn(II) Complexes from DTPA-Bisamide Derivative As Potential MRI Contrast Agents

Studies on D-galactose-containing DTPA bisamide gadolinium complexes as liver-targeting MRI contrast agents

Safe and Potent MRI Contrast Agents by Complexing Gadolinium with Enzyme/reduction Dual-Sensitive Branched Polymers

A dendronized heparin–gadolinium polymer self-assembled into a nanoscale system as a potential magnetic resonance imaging contrast agent

Reductive Microenvironment Responsive Gadolinium-Based Polymers As Potential Safe MRI Contrast Agents

Functional Hyperbranched Polylysine As Potential Contrast Agent Probes for Magnetic Resonance Imaging

Porphyrin-containing polyaspartamide gadolinium complexes as potential magnetic resonance imaging contrast agents

PEGylated Amphiphilic Gd-DOTA Backboned-Bound Branched Polymers As Magnetic Resonance Imaging Contrast Agents.

Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI

Arabinogalactan As A Carrier for Contrast Agent in Magnetic Resonance Imaging